Arthritis & Rheumatism

Patients with lupus benefit from COVID-19 vaccine booster

People with systemic lupus erythematosus (SLE) who received a "booster" dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent "breakthrough" COVID-19 infection, a new study shows.

Psychology & Psychiatry

Low self-esteem linked to anxiety/depression in SLE

(HealthDay)—For patients with systemic lupus erythematosus (SLE), measures of psychosocial reserve capacity may be associated with depression and anxiety, according to a study published online March 6 in the International ...

Neuroscience

A new drug to manage resistant chronic pain

Neuropathic pain, caused by nerve or tissue damage, is the culprit behind many cases of chronic pain. It can be the result of an accident or caused by a variety of medical conditions and diseases such as tumors, lupus, and ...

Immunology

Breakthrough opens door to safer lupus drugs

A ground-breaking discovery by Monash University researchers could revolutionise treatments given to lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections.

page 8 from 40